The acute coronary syndrome sub-segment under application segment is projected to dominate the global “cardiac biomarkers market during the forecast period. It is likely to occur due to a rise in the investment by various health institutes in biomarker testing for early detection of the disease. This information is given in an upcoming report by Fortune Business Insights, titled, “Cardiac Biomarkers Market Size “ and Global Trend By Type (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), Myoglobin), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End User (Hospitals, Diagnostic Centers, Homecare Settings) and Geography Forecast till 2026.
The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Request a Sample Copy of the Research Report:
What does the Report Include?
The market report includes quantitative and qualitative analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers the different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves leading companies and adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will contribute to the growth of the market between 2020 and 2027. Moreover, the research analyst has adopted several research methodologies such as PESTEL and SWOT analysis to extract information about the current trends and industry developments that will drive the market growth in the forthcoming years.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
For More Information Visit : https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233
Key Companies and Manufacturers Covered:
- Thermo Fisher Scientific
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Randox Laboratories Ltd.
- Beckman Coulter, Inc.
- Dickinson and Company
- Dickinson and Company
- bioMérieux SA
- Other key market players
Key Features of Cardiac Biomarkers Market Report:
- Overview, Industry Life Cycle Analysis, Supply Chain Analysis
- Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
- Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
- Market attractiveness and Associated Growth Opportunities
- Strategic Growth Opportunities for the Existing and New Players
- Key Success Factors
Persistent Technological Advancement for Developing Biomarkers to Drive Global Market
Fortune Business Insights states in the report that the main reason behind the ever-increasing demand for cardiac biomarkers is because of the rising incidence of cardiovascular diseases, which, in turn, is increasing the demand for early detection of the diseases. Moreover, innovative product launches by prominent market players and increasing fast track approvals are expected to drive the global cardiac biomarkers market growth in the forecast period. Also, a rise in the technological advancements in the field of cardiac biomarkers and increasing demand for point of care testing kits are likely to contribute to the global market growth in the upcoming years.
Siemens and Roche Receive FDA Clearance for Their Products to Aid in Early Detection of Heart Attack
Siemens Healthineers, a prominent healthcare company, based in Germany, announced in July 2018 that it bagged FDA approval for high-sensitivity troponin I assays (TnIH). They would be used on the company’s Advia Centaur XP/XPT as well as Atellica IM immunoassay analyzers. It would further support in the early diagnosis of heart attacks or myocardial infarctions. Siemens declared that the two TnIH assays possess high sensitivity. Therefore, it would aid in detecting minute changes in troponin levels in patients as well as finding lower levels of troponin. The testing has to be conducted repeatedly to achieve the desired results. That is why doctors and clinicians would gain more confidence in the results and immediately begin treatment of the same.
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/cardiac-biomarkers-market-101233
Cardiac Biomarkers Market Segmentation:
- Creatine kinase-MB (CK-MB)
- B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP)
- Acute Coronary Syndrome
- Myocardial Infarction
- Congestive Heart Failure
By End User
- Diagnostic Centers
- Homecare Settings
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Quick Buy – Cardiac Biomarkers Market Research Report:
Reasons to Purchase this Report:
- Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players.
- Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion.
- Market dynamics and opportunities for growth for players in the near future.
- Competitive landscape describing the market revenue shares of key players.
- Market segmentation analysis that deals with quantitative and qualitative research, discussing the influence of policy-based and economical aspects.
Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
A market study that conducts at Fortune Business Insights can save significant cost and time, and can help prevent making costly mistakes.
Secondary Data Sources That We Refer To:
- Annual reports, investor presentation, SEC filings, and press releases of companies operating in the market
- Studies published by relevant associations MedTech Europe; American College of Radiology; Cancer Council Australia; Japan Hospital Association, etc.), government sources (Centers for Disease Control & Prevention, Ministry of Health, Labour & Welfare, Japan; National Health Service, England, etc.), international organizations (World Health Organization, The Organization for Economic Co-operation and Development, Eurostat, etc.), and articles published by Research Gate, NCBI, etc.
- Website, reports, and press releases of end user facilities – Hospitals, Ambulatory Surgery Centres, Clinics
- Industry journals and paid databases
Secondary Research Is Conducted To Derive The Following Information:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
- Number of procedures and average price of procedures
- Replacement rate and pricing of capital equipment
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
- Market & technological trends, new product developments, product pipeline.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Related Reports :